Skip to main content
TipRanks
Go Ultimate75% OFF

Endonovo Therapeutics (ENDV) Revenue

24 Followers

Endonovo Therapeutics Revenue

Revenue (ttm)
0.00
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
1
Market Cap
$1,808

Revenue Chart

Endonovo Therapeutics Revenue - Annual

050K100K150K200K250K300K350K83.26K310.16K165.80K73.11K135.35K140.24K10.04K201720182020202120222022202320242025
Revenue History
Download to Excel
ENDV revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20250.00-10.04K-100.00%
Dec 31, 202410.04K-130.20K-92.84%
Dec 31, 2023140.24K4.89K3.61%
Dec 31, 2022135.35K62.25K85.15%
Mar 31, 202273.11K-92.69K-55.91%
Mar 31, 2021165.80K-144.37K-46.55%
Mar 31, 2020310.16K226.90K272.51%
Dec 31, 201883.26K83.26K―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
ENDV0.00
NUWE9.01M
SCNI3.08M
PRFX39.50K
DRMA0.00
BJDX0.00